For patients and carers
An injectable collagen implant that sets firm in damaged cartilage.
ChondroFiller® liquid is a collagen implant made from purified animal collagen, as described in the published literature. It is injected as a liquid and sets firm within minutes, forming a collagen scaffold in the damaged area. The manufacturer describes it as a resorbable implant that gives your own cells a framework to move into.

Healthcare professional? Product information, technique, evidence, training and UK ordering are in the professional section.
Enter the professional sectionIn short
- It is made from purified animal collagen, as described in the published literature.1
- It is injected as a liquid and sets firm within minutes, forming a collagen scaffold in the damaged area. Depending on the joint, it is given as an ultrasound-guided injection or during keyhole surgery.9,10
- Whether it is an option for you is decided by the surgeon who examines you and looks at your scans.
- It is manufactured by Meidrix Biomedicals GmbH, Esslingen, Germany.

Who it may be for
Whether ChondroFiller is worth considering for you.

ChondroFiller® liquid is used to fill cartilage damage in joints such as the knee, hip, shoulder and ankle, following the manufacturer’s intended use.8
Whether it is an option for your joint is a decision for the surgeon who examines you and looks at your scans. The published studies cover the knee, hip and ankle, with follow-up of one to five years.2,4,7
What happens
From consultation to treatment and follow-up.

Step 01
Consultation and imaging
A surgeon assesses your joint, your history and your scans, and discusses whether ChondroFiller is worth considering for you.
Step 02
Decision with the surgeon
You and your surgeon decide together whether to go ahead. Clinics set their own fees; ask the clinic.
Step 03
Treatment
ChondroFiller is injected into the damaged area of cartilage and sets firm within minutes, forming a collagen scaffold. Depending on the joint and your surgeon, it is given as an ultrasound-guided injection without surgery, or during keyhole (arthroscopic) surgery.
Step 04
Recovery and follow-up
Your surgeon will talk you through aftercare and arrange follow-up.
What the studies found
The published evidence, in plain English.
The published research on ChondroFiller liquid consists of small studies, mostly single-arm, followed for between one and five years, with two series extending to five years or more. Results vary between studies and no large UK trial has been published. Ask a clinic what the evidence means for your own joint.4,5,6,7,2
The manufacturer states: 'In rare cases, hypersensitivity reactions to collagen such as allergic or inflammatory reactions can occur.' No adverse events were reported in the published multicentre trial of 23 randomised patients, 13 of whom received ChondroFiller. If you notice anything you are concerned about after treatment, contact the clinic that treated you.8,2
Your clinician decides
Studies mentioned on this page
- 1.Perez-Carro L, Mendoza Alejo PR, Gutierrez Castanedo G, Menendez Solana G, Fernandez Divar JA, Galindo Rubin P, Alfonso Fernandez A. Hip Chondral Defects: Arthroscopic Treatment With the Needle and Curette Technique and ChondroFiller. Arthroscopy Techniques, 10(7):e1669-e1675, 2021. View DOI
- 2.Schneider U. Controlled, randomized multicenter study to compare compatibility and safety of ChondroFiller liquid (cell free 2-component collagen gel) with microfracturing of patients with focal cartilage defects of the knee joint. Video Journal of Orthopedics Surgery, 1:1-8, 2016. View DOI
- 3.Meidrix Biomedicals GmbH. ChondroFiller® liquid overview brochure. Manufacturer publication, 2024. View source
- 4.Mazek J, Gnatowski M, Salas AP, O’Donnell JM, Domżalski M, Radzimowski J. Arthroscopic utilization of ChondroFiller gel for the treatment of hip articular cartilage defects: a cohort study with 12- to 60-month follow-up. Journal of Hip Preservation Surgery, 8(1):22, 2021. View DOI
- 5.Simeonov E. Implantation of ChondroFiller Liquid as a Scaffold Material for the Treatment of Chondral Lesions of the Knee Joint. Journal of IMAB, 30(4):5936-5941, 2024. View DOI
- 6.De Lucas Villarrubia JC, Méndez Alonso MÁ, Sanz Pérez MI, Trell Lesmes F, Panadero Tapia A. Acellular Matrix-Induced Chondrogenesis Technique Improves the Results of Chondral Lesions Associated with Femoroacetabular Impingement. Arthroscopy, 2021. View DOI
- 7.Gatti SD, Vermorel PH, Vega J, Batista J, Guelfi M. Clinical and functional outcomes of arthroscopic autologous collagen-induced chondrogenesis (ACIC) for osteochondral lesions of the talus: A retrospective case series. Journal of Experimental Orthopaedics, 13(1):e70642, 2026. View DOI
- 8.Meidrix Biomedicals GmbH. ChondroFiller® liquid patient education leaflet. Manufacturer publication, 2022. View source
- 9.Meidrix Biomedicals GmbH. ChondroFiller® liquid product page. Meidrix Biomedicals GmbH, 2026. View source
- 10.Meidrix Biomedicals GmbH. ChondroFiller® liquid: treatment for rhizarthrosis (F02EN/V002). Manufacturer publication, 2026. View source
Talk to your clinician about ChondroFiller.
This website provides information, not clinical advice. Only a clinician who has examined you and seen your scans can say whether ChondroFiller is an option for you.